About
Moderna, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 1 2026
Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates
Apr 21 2026
Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate
Apr 17 2026
Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or Metastatic Melanoma at the 2026 AACR Annual Meeting
Apr 15 2026
Moderna to Report First Quarter 2026 Financial Results on Friday, May 1, 2026
Apr 6 2026
Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026
Recent Videos

🚨💉🦠 ** MODERNA ANNOUNCES HANTAVIRUS VACCINE DEVELOPMENT ** #hantavirus #moderna #vacine
May 09, 2026

India's Vaccine Manufacturing Pivot: How Moderna's mRNA Flu Win Threatens Serum Institute's $8B Domi
May 09, 2026

Moderna Vacuna Hantavirus #HTBN #hoyestendenciabreakingnews I @Hoyestendenciabreakingnews
May 08, 2026

j'ai anticipé l'annonce de Moderna sur le vaccin Hantavirus #Moderna #Trading #Hantavirus
May 08, 2026
Translate